SIGN IN YOUR ACCOUNT TO HAVE ACCESS TO DIFFERENT FEATURES

FORGOT YOUR PASSWORD?

FORGOT YOUR DETAILS?

AAH, WAIT, I REMEMBER NOW!

MITUMITU

info@mitu.or.tz | +255 28 2500019 | Staff Mail
  • LOGIN
  • WHO WE ARE
    • History & Background
    • Mission & Values
    • Strategic Plan
    • Organization Structure
    • Our Team
  • WHERE WE ARE
    • Mwanza Medical Research Centre
    • Mwanza City
  • WHAT WE DO
    • Research Programme
    • Capacity Building
    • Research Facilities
  • PUBLICATIONS
  • NEWS & EVENTS
    • News & Events
    • Career
  • CONTACT US
Wednesday, 17 June 2020 / Published in Uncategorized

A low-cost drug found to reduce death by up to one third in hospitalised patients with severe COVID-19

We have new exciting news about a low cost drug which has been found to be effective in treating severe COVID-19 cases. See attached PDF file.
[easy_media_download url=”https://mitu.or.tz/wp-content/uploads/2020/06/Recovery-trial-effect-of-dexamethasone-on-severe-covid-19-disease.pdf” text=”Download PDF ” force_dl=”1″ class=”btn-warning”]

  • Tweet
  • Share 0
  • Pocket
  • LinkedIn 0
  • Email

What you can read next

The Vaginal Microbiota Among Adolescent Girls in Tanzania Around the Time of Sexual Debut
Contested or complementary healing paradigms? Women’s narratives of COVID-19 remedies in Mwanza, Tanzania.
First Meeting of the Task Force on COVID-19 Vaccines, Therapeutics and Diagnostics for Developing Countries

Filter by Year

  • All Publications
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003

Recent Posts

  • Job Vacancy: Senior Finance Officer

  • MITU launches a new human papilloma virus (HPV) vaccine trial among boys in  Tanzania

  • Same habitus in new field? How mobile phone communication reproduces masculinities and gender inequality in intimate relationships in Mwanza, Tanzania.

  • Comparison of Immune Responses after One Dose of HPV Vaccine in a Dose-Reduction HPV Vaccine Trial in Adolescent Girls in Tanzania to the Costa Rica Vaccine and India HPV Vaccine Trials.

  • Immunogenicity and Safety Results Comparing Single Dose Human Papillomavirus Vaccine with Two or Three Doses in Tanzanian Girls – the DoRIS Randomised Trial.

Receive our latest news straight to your inbox

Join 224 other subscribers

CONTACT US

Contact us through the address below
Mwanza Intervention Trials Unit.

MITU, Isamilo Street,
P.O. Box11936,
Mwanza, Tanzania.

info@mitu.or.tz

+255 28 2500019

WHO WE ARE

  • History & Background
  • Mission & Values
  • Strategic Plan
  • Organization Structure
  • Our Team

WHAT WE DO

  • Research Programme
  • Capacity Building
  • Research Facilities

OUR SOCIAL

  • Facebook
  • Twitter
  • LinkedIn
  • Instagram

OUR PARTNERS

Tweets by mituorg
© 2021 MITU | All rights reserved.
TOP